FDA releases virginiamycin risk assessment; findings demonstrate the use of virginiamycin in animals poses no significant threat to human health.

(From Chemical Business NewsBase - Press Release)

Phibro Animal Health Corp announced that the Center for Veterinary Medicine (CVM) of the Food and Drug Administration (FDA) has released the findings of its draft risk assessment for the animal drug virginiamycin. In the FDA's draft report, the authors demonstrate that the continued use of virginiamycin (a medicated feed additive manufactured and marketed by Phibro Animal Health) in livestock and poultry feed poses no significant risk to human health. The FDA findings are consistent with extensive analysis conducted on behalf of Phibro …